Medical Access Program for Patritumab Deruxtecan
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Clinical Trials Related to Daiichi Sankyo
Related studies linked through entity extraction aliases.
T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Predictors of Clinical Outcomes in Patients With HR+ and HER2-low/Negative Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Basket Study for Oligo-metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
National Register of Actionable Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Future Innovations in Novel Detection for Atrial Fibrillation (FIND-AF): Pilot Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases
- Status
- RECRUITING
- Phase
- PHASE2
HER3-DXd in Breast Cancer and NSCLC Brain Metastases and Solid Tumor Leptomeningeal Disease
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate Effectiveness and Safety of Edoxaban in Patients 80 Years of Age or Older With Nonvalvular Atrial Fibrillation
- Status
- COMPLETED
- Phase
- N/A
TRUDI: TDXD+Durva in HER2+/Low IBC
- Status
- RECRUITING
- Phase
- PHASE2
A Study of Prevalence of HER3 Expression in Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study to Describe the Real-world Treatment Patterns and Associated Outcomes in Patients of China With HER2-positive Unresectable or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
A Study of DS-1103a Combination Therapy in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Phase 1/2, Open-label Study of Valemetostat in Combination With Rituximab and Lenalidomide in Relapsed or Refractory Follicular Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of DS-7011a in Patients With Systemic Lupus Erythematosus
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase 1b Study of EZH1/2 Inhibitor Valemetostat in Combination With Trastuzumab Deruxtecan in Subjects With HER2 Low/Ultra-low/Null Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3